Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology at The University of Manchester, shared a post on LinkedIn:
“It is a real privilege to attend the first consensus meeting on non-metastatic NSCLC in Barcelona, bringing together over 100 leading international thoracic oncology experts
Across three days, we are addressing:
• grey zones in biomarkers and imaging.
• management of resectable stage I–II and stage III NSCLC.
• treatment challenges in unresectable stage III NSCLC.”
More posts featuring Corinne Faivre-Finn.